These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

485 related articles for article (PubMed ID: 29251726)

  • 1. Orthologous CRISPR-Cas9 enzymes for combinatorial genetic screens.
    Najm FJ; Strand C; Donovan KF; Hegde M; Sanson KR; Vaimberg EW; Sullender ME; Hartenian E; Kalani Z; Fusi N; Listgarten J; Younger ST; Bernstein BE; Root DE; Doench JG
    Nat Biotechnol; 2018 Feb; 36(2):179-189. PubMed ID: 29251726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative optimization of combinatorial CRISPR screens.
    Li R; Klingbeil O; Monducci D; Young MJ; Rodriguez DJ; Bayyat Z; Dempster JM; Kesar D; Yang X; Zamanighomi M; Vakoc CR; Ito T; Sellers WR
    Nat Commun; 2022 May; 13(1):2469. PubMed ID: 35513429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. sgRNA Scorer 2.0: A Species-Independent Model To Predict CRISPR/Cas9 Activity.
    Chari R; Yeo NC; Chavez A; Church GM
    ACS Synth Biol; 2017 May; 6(5):902-904. PubMed ID: 28146356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRISPR-Cas9 screens reveal common essential miRNAs in human cancer cell lines.
    Merk DJ; Paul L; Tsiami F; Hohenthanner H; Kouchesfahani GM; Haeusser LA; Walter B; Brown A; Persky NS; Root DE; Tabatabai G
    Genome Med; 2024 Jun; 16(1):82. PubMed ID: 38886809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional Regulation with CRISPR/Cas9 Effectors in Mammalian Cells.
    Pham H; Kearns NA; Maehr R
    Methods Mol Biol; 2016; 1358():43-57. PubMed ID: 26463376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A CRISPR Resource for Individual, Combinatorial, or Multiplexed Gene Knockout.
    Erard N; Knott SRV; Hannon GJ
    Mol Cell; 2017 Jul; 67(2):348-354.e4. PubMed ID: 28732207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. sgRNA Sequence Motifs Blocking Efficient CRISPR/Cas9-Mediated Gene Editing.
    Graf R; Li X; Chu VT; Rajewsky K
    Cell Rep; 2019 Jan; 26(5):1098-1103.e3. PubMed ID: 30699341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome Editing with CRISPR-Cas9: Can It Get Any Better?
    Haeussler M; Concordet JP
    J Genet Genomics; 2016 May; 43(5):239-50. PubMed ID: 27210042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual gene activation and knockout screen reveals directional dependencies in genetic networks.
    Boettcher M; Tian R; Blau JA; Markegard E; Wagner RT; Wu D; Mo X; Biton A; Zaitlen N; Fu H; McCormick F; Kampmann M; McManus MT
    Nat Biotechnol; 2018 Feb; 36(2):170-178. PubMed ID: 29334369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pooled Lentiviral CRISPR-Cas9 Screens for Functional Genomics in Mammalian Cells.
    Aregger M; Chandrashekhar M; Tong AHY; Chan K; Moffat J
    Methods Mol Biol; 2019; 1869():169-188. PubMed ID: 30324523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISPR-Mediated Transcriptional Repression in Toxoplasma gondii.
    Markus BM; Boydston EA; Lourido S
    mSphere; 2021 Oct; 6(5):e0047421. PubMed ID: 34643425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combinatorial single-cell CRISPR screens by direct guide RNA capture and targeted sequencing.
    Replogle JM; Norman TM; Xu A; Hussmann JA; Chen J; Cogan JZ; Meer EJ; Terry JM; Riordan DP; Srinivas N; Fiddes IT; Arthur JG; Alvarado LJ; Pfeiffer KA; Mikkelsen TS; Weissman JS; Adamson B
    Nat Biotechnol; 2020 Aug; 38(8):954-961. PubMed ID: 32231336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parallel CRISPR-Cas9 screens clarify impacts of p53 on screen performance.
    Bowden AR; Morales-Juarez DA; Sczaniecka-Clift M; Agudo MM; Lukashchuk N; Thomas JC; Jackson SP
    Elife; 2020 May; 9():. PubMed ID: 32441252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of Staphylococcus aureus Cas9: a smaller Cas9 for all-in-one adeno-associated virus delivery and paired nickase applications.
    Friedland AE; Baral R; Singhal P; Loveluck K; Shen S; Sanchez M; Marco E; Gotta GM; Maeder ML; Kennedy EM; Kornepati AV; Sousa A; Collins MA; Jayaram H; Cullen BR; Bumcrot D
    Genome Biol; 2015 Nov; 16():257. PubMed ID: 26596280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole genome analysis of CRISPR Cas9 sgRNA off-target homologies via an efficient computational algorithm.
    Zhou H; Zhou M; Li D; Manthey J; Lioutikova E; Wang H; Zeng X
    BMC Genomics; 2017 Nov; 18(Suppl 9):826. PubMed ID: 29219081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid and efficient one-step generation of paired gRNA CRISPR-Cas9 libraries.
    Vidigal JA; Ventura A
    Nat Commun; 2015 Aug; 6():8083. PubMed ID: 26278926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient gene knockout and genetic interaction screening using the in4mer CRISPR/Cas12a multiplex knockout platform.
    Esmaeili Anvar N; Lin C; Ma X; Wilson LL; Steger R; Sangree AK; Colic M; Wang SH; Doench JG; Hart T
    Nat Commun; 2024 Apr; 15(1):3577. PubMed ID: 38678031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rational design of highly active sgRNAs for CRISPR-Cas9-mediated gene inactivation.
    Doench JG; Hartenian E; Graham DB; Tothova Z; Hegde M; Smith I; Sullender M; Ebert BL; Xavier RJ; Root DE
    Nat Biotechnol; 2014 Dec; 32(12):1262-7. PubMed ID: 25184501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, execution, and analysis of pooled in vitro CRISPR/Cas9 screens.
    Miles LA; Garippa RJ; Poirier JT
    FEBS J; 2016 Sep; 283(17):3170-80. PubMed ID: 27250066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Doxycycline-Dependent Self-Inactivation of CRISPR-Cas9 to Temporally Regulate On- and Off-Target Editing.
    Kelkar A; Zhu Y; Groth T; Stolfa G; Stablewski AB; Singhi N; Nemeth M; Neelamegham S
    Mol Ther; 2020 Jan; 28(1):29-41. PubMed ID: 31601489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.